Signaling pathways of mechanotransduction in arteriolar endothelium and smooth muscle cells in hypertension

Microcirculation

Volumn 9, Issue 4, 2002, Pages 277-294

  Koller, Akos ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Arterioles; Endothelium; Hypertension; Pressure; Shear stress; Smooth muscle

Indexed keywords

ANIMAL; ARTERY; ARTICLE; CYTOLOGY; FEEDBACK SYSTEM; HUMAN; HYPERTENSION; MECHANOTRANSDUCTION; METABOLISM; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

ANIMALS; ARTERIES; ENDOTHELIUM, VASCULAR; FEEDBACK, PHYSIOLOGICAL; HUMANS; HYPERTENSION; MECHANOTRANSDUCTION, CELLULAR; MUSCLE, SMOOTH, VASCULAR; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 0000639918     PISSN: 10739688     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mn.7800142     Document Type: Article

References (151)

1. Allen SP, Wade SS, Prewitt RL. (1997). Myogenic tone attenuates pressure-induced gene expression in isolated small arteries. Hypertension 30(part 1): 203-208.
2. Arnal J-F, Yamin J, Dockery S, Harrison DG. (1994). Regulation of endothelial nitric oxide synthase mRNA, protein, and activity during cell growth. Am J Physiol 267(pt 1):C1381-C1388.
3. Altura, BM. (1975). Sex and estrogens and responsiveness of terminal arterioles to neurohypophysial hormones and catecholamines. J Pharmacol Exp Ther 193:403-412.
4. Arner A, Malmqvist U, Uvelius B. (1984). Structural and mechanical adaptations in rat aorta in response to sustained changes in arterial pressure. Acta Physiol Scand 122:119-126.
5. Bakker ENTP, Kerkhof CJM, Sipkema P. (1999). Signal transduction in spontaneous myogenic tone in isolated arterioles from rat skeletal muscle. Cardiovasc Res 41:229-236.
6. Bian K, Bukoski RD. (1995). Myofilament calcium sensitivity of normotensive and hypertensive resistance arteries. Hypertension 25:110-116.
7. Boegehold MA. (1992). Reduced influence of nitric oxide on arteriolar tone in hypertensive Dahl rats. Hypertension 19:290-295.
8. Bohlen HG. (1979). Arteriolar closure mediated by hyperresponsiveness to norepinephrine in hypertensive rats. Am J Physiol 236(5): H157-H164.
9. Bonnardeaux A, Nadaud S, Charru A, Jeunemaitre X, Corvol P, Soubrier F. (1995). Lack of evidence for linkage of the endothelial cell nitric oxide synthase gene to essential hypertension. Circulation 91:L96-L102.
10. Brosnihan KB, Moriguchi A, Nakamoto H, Dean RH, Ganten D, Ferrario CM. (1994). Estrogen augments the contribution of nitric oxide to blood pressure regulation in transgenic hypertensive rats expressing the mouse Ren-2 gene. Am J Hypertension 7:576-582.
11. 2+ during acetylcholine-induced dilation of microvessels. Br J Pharmacol 128:124-134.
12. Bryan RM Jr, Marrelli SP, Steenberg ML, Schildmeyer LA, Johnson TD. (2001). The effects of luminal shear stress on cerebral arteries and arterioles. Am J Physiol 280:H2011-H2022.
13. Bund SJ, West KP, Heagerty AM. (1991). Effects of protection from pressure on resistance artery morphology and reactivity in spontaneously hypertensive and WKY rats. Circ Res 68:1230-1240.
14. Cardillo C, Kilcoyne CM, Quyyumi AA, Cannon RO, Panza JA. (1998). Selective defect in nitric oxide synthesis may explain the impaired endothelium-dependent vasodilation in patients with essential hypertension. Circulation 97:851-856.
15. Cernadas MR, de Miguel LS, Garcia-Duran M, Gonzalez-Fernandez F, Millas I, Monton M, Rodrigo J, Rico L, Fernandez P, de Frutos T, Rodriguez-Feo JA, Guerra J, Caramelo C, Casado S, Lopez-Farre A. (1998). Expression of constitutive and inducible nitric oxide synthases in the vascular wall of young and aging rats. Circ Res 83:279-286.
16. Chou, Tz-C, Yen M-H, Li C-Y, Ding Y-A. (1998). Alterations of nitric oxide synthase expression with aging and hypertension in rats. Hypertension 3: 643-648.
17. 2+ influx. Circ Res 84:210-219
18. Colburn P, Buonassisi V. (1978). Estrogen-binding sites in endothelial cell cultures. Science 201:817-819.
19. Cosentino F, Katusic ZS. (1995). Tetrahydrobiopterin and dysfunction of endothelial nitric oxide synthase in coronary arteries. Circulation 91:139-144.
20. D'Angelo C, Davis MJ, Meininger GA. (1997). Calcium and mechanotransduction of the myogenic response. Am J Physiol 273:H175-H182.
21. Davis MJ, Wu X, Nurkiewicz TR, Kawasaki J, Davis GE, Hill MA, Meininger GA. (2001). Integrins and mechanotransduction of the vascular myogenic response. Am J Physiol Heart Circ Physiol 280:H1427-H1433.
22. DeBruyn VH, Nuno DW, Capelli-Bigazzi M, Dole WP, Lamping KG. (1994). Effect of acute hypertension in the coronary circulation: role of mechanical factors and oxygen radicals. J Hypertension 12(2):163-172.
23. DeLano FA, Schmid-Schöenbein GW. 2001. Visualization of oxidative stress enzyme markers within a microvascular network. Proceedings of the 7th World Congress for Microcirculation, Sidney, Australia.
24. DeLano, FA, Schmid-Schöenbein GW, Skalak TC, Zweifach BW. (1991). Penetration of the systemic blood pressure into the microvasculature of rat skeletal muscle. Microvasc Res 41:92-110.
25. Dietrich HH, Kimura M, Dacey RG Jr. (1994). N-ω-nitro-L-arginine constricts cerebral arterioles without increasing intracellular calcium levels. Am J Physiol 266:H1681-H1686.
26. Douglas SA, Gellai M, Ezekiel M, Ohlstein EH. (1994). BQ-123, a selective endothelin subtype A-receptor antagonist, lowers blood pressure in different rat models of hypertension. J Hypertension 12: 561-567.
27. Dutrait N, Culcasi M, Cazevieille C, Pietri S, Tordo P, Bonne C, Muller A. (1995). Calcium-dependent free radical generation in cultured retinal neurons injured by kainate. Neurosci Lett 198(1):13-16.
28. Falcone JC, Granger HJ, Meininger GA. (1993). Enhanced myogenic activation in skeletal muscle arterioles from spontaneously hypertensive rats. Am J Physiol 265:H1847-H1855.
29. Falcone JC, Meininger GA. (1999). Endothelin mediates a component of the enhanced myogenic responsiveness of arterioles from hypertensive rats. Microcirculation 6:305-313.
30. Farhat MY, Lavigne MC, Ramwell PW. (1996). The vascular protective effects of estrogen. FASEB J 10: 615-624.
31. Folkow B. (1989). Functional and structural "auto-regulation": some personal considerations concerning the century-old development of these microvascular concepts. Microvasc Res 37:243-255.
32. Fu-Xiang D, Jameson M, Skopec J, Diederich A, Diederich D. (1992). Endothelial dysfunction of resistance arteries of spontaneously hypertensive rats. J Cardiovasc Pharmacol 20:S190-S192.
33. 2 in the SHR aorta. Circ Res 76:1003-1010.
34. 2+ sensitivity as a key mechanism of PKC-induced constriction in pressurized cerebral arteries. Am J Physiol 277:H1178-H1188.
35. 2+ sensitivity in pressurized rat cerebral arteries. Am J Physiol 274:H1920-H1927.
36. Gorlach C, Benyo Z, Wahl M. (1998). Endothelin-1-induced contraction in cerebral vessels mediated by phospholipase C/protein kinase C cascade. Kidney Int (Suppl) 67:S224-S225.
37. Grunfeld S, Hamilton CA, Mesaros S, McLain SW, Dominiczak AF, Bohr DF, Malinski T. (1995). Role of superoxide in the depressed nitric oxide production by the endothelium of genetically hypertensive rats. Hypertension 26(part 1):854-857.
38. Gura T. (1995). Estrogen: key player in heart disease among women. Science 269:771-773.
39. Hajdu MA, Rodenburg JM, Kaley G, Koller A. (1993). Effects of hypertension on sensitivity of arteriolar smooth muscle to endothelium derived vasodilator factors. FASEB J 7(4):A557(#3230).
40. Harder DR, Sanchez-Ferrer C, Kauser K, Stekiel WJ, Rubanyi GM. (1989). Pressure releases a transferable endothelial contractile factor in cat cerebral arteries. Circ Res 56:193-198.
41. Hayashi K, Epstein M, Loutzenhiser R. (1992). Enhanced myogenic responsiveness of renal interlobular arteries in spontaneously hypertensive rats. Hypertension 19:153-160.
42. Henriksen O, Skagen K, Amtorp O, Hartling O. (1981). Augmented vasoconstrictor response to changes in vascular transmural pressure in patients with essential arterial hypertension. Acta Physiol Scand 112:323-329.
43. Henrion D, Benessiano J, Levy BI. (1997). In vitro modulation of a resistance artery diameter by the tissue renin-angiotensin system of a large donor artery. Circ Res 80:189-195.
44. Henrion, D, Iglarz, M, Levy, BI. (1999). Chronic endothelin-1 improves nitric oxide-dependent flow-induced dilation in resistance arteries from normotensive and hypertensive rats. Arterioscler Thromb Vasc Biol 19:2148-2153.
45. Heog JM, Willis LR, Weinberger MH. (1977). Estrogen attenuation of the development of hypertension in spontaneous hypertension rats. Am J Physiol 233:H369-H373.
46. i are not obligatory for myogenic constriction. Am J Physiol Heart Circ Physiol 278:H345-H352.
47. Hirata MK, Kohse P, Chang CH, Ikebe T, Murad F. (1990). Mechanism of cyclic GMP inhibition of inositol phosphate formation in rat aorta segments and cultured bovine aortic smooth muscle cells. J Biol Chem 265:1268-1273.
48. Hishikawa K, Nakaki T, Suzuki H, Saruta T, Kato R. (1992). Transmural pressure inhibits nitric oxide release from human endothelial cells. Eur J Pharmacol 215:329-331.
49. Hsieh HJ, Cheng CC, Wu ST, Chiu JJ, Wung BS, Wang DL. (1998). Increase of reactive oxygen species (ROS) in endothelial cells by shear flow and involvement of ROS in shear-induced c-fos expression. J Cell Physiol 175:156-162.
50. Huang A, Sun D, Koller A. (1993). Endothelial dysfunction augments myogenic arteriolar constriction in hypertension. Hypertension 22:913-921.
51. Huang A, Koller A. (1996). Both nitric oxide and prostaglandin-mediated responses are impaired in skeletal muscle arterioles of hypertensive rats. Hypertension 14:887-895.
52. 2 enhance arteriolar myogenic tone in hypertension. Hypertension 30:1210-1215.
53. Huang A, Sun D, Kaley G, Koller A. (1998). Superoxide released to high intra-arteriolar pressure reduces nitric oxide-mediated shear stress- and agonist-induced dilations. Circ Res 83(9):960-965.
54. 2 in arterioles of hypertensive rats. Hypertension 35:925-930.
55. Huang A, Sun D, Kaley G, Koller A. (1997). Estrogen maintains nitric oxide synthesis in arterioles of female hypertensive rats. Hypertension 29:1351-1356.
56. Huang, A, Sun D, Kaley G, Koller A. (1998). Estrogen preserves regulation of shear stress by nitric oxide in arterioles of female hypertensive rats. Hypertension 31 (part 2):309-314.
57. Hutchins PM, Lynch CD, Cooney PT, Curseen KA. (1996). The microcirculation in experimental hypertension and aging. Cardiovasc Res 32:772-780.
58. Iams SG, Wexler BC. (1979). Inhibition of the development of spontaneous hypertension in SH rats by gonadectomy or estradiol. J Lab Clin Med 10: 608-616.
59. Ishii K, Suita S, Sumimoto H. (1990). Effect of verapamil on conversion of xanthine dehydrogenase to oxidase in ischemic rat liver. Res Exp Med 190(6): 389-399.
60. Izzard AS, Bund SJ, Heagerty AM. (1996). Myogenic tone in mesenteric arteries from spontaneously hypertensive rats. Am J Physiol 270:H1-H6.
61. Jacinto SM, Jandhyala BS. (1992). Evaluation of the effect of felodipine, verapamil and hydralazine on the survival rate of rats subjected to lethal effect of oxygen free radicals. Naunyn Scmiedebergs Arch Pharmacol 346(4):457-461.
62. Jiang C, Sarrel PM, Poole-Wilson PA, Collins P. (1992). Acute effect of 17β-estradiol on rabbit coronary artery contractile responses to endothelin-1. Am J Physiol 263(32):H271-H275.
63. Johnson PC. (1989). The myogenic response in the microcirculation and its interaction with other control systems. J Hypertension (Suppl.) 7:S33-S39.
64. 2+ and protein kinase C in developing myogenic contraction in isolated rat small arteries. Am J Physiol 272:H1165-H1172.
65. Kauser K, Rubanyi GM. (1994). Gender difference in bioassayable endothelium-derived nitric oxide from isolated rat aortae. Am J Physiol 267(36): H2311-H2317.
66. Kirton CA, Loutzenhiser R. (1998). Alterations in basal protein kinase C activity modulate renal afferent arteriolar myogenic reactivity. Am J Physiol 275:H467-H475.
67. Kitazawa T, Eto M, Woodsome TP, Brautigan DL. (2000). Agonists trigger G protein-mediated activation of the CPI-17 inhibitor phosphoprotein of myosin light chain phosphatase to enhance vascular smooth muscle contractility. J Biol Chem 275:9897-9900.
68. 2+] in cerebral arteries of rat by membrane potential and intravascular pressure. J Physiol 508:199-209.
69. 2+-free media are mediated by different signal transduction pathways in rat aorta. Br J Pharmacol 110:875-881.
70. Koller A, Huang A. (1995). Shear stress-induced dilation is attenuated in skeletal muscle arterioles of hypertensive rats. Hypertension 25(part 2):758-763.
71. Koller A, Kaley G. (1996). Shear stress dependent regulation of vascular resistance in health and disease: role of endothelium. Endothelium 4:247-272.
72. Koller A, Huang A. (1994). Impaired nitric oxide-mediated flow-induced dilation in arterioles of spontaneously hypertensive rats. Circ Res 74:416-421.
73. Koller A, Huang A. (1999). Development of nitric oxide and prostaglandin mediation of shear stress-induced arteriolar dilation with aging and hypertension. Hypertension 34:1073-1079.
74. Koller A, Huang A. (2002). Xanthine oxidase-derived superoxide release to high intraarteriolar pressure impairs nitric oxide-mediated flow induced dilation. FASEB J 16(4):A428(#378.1).
75. Koller A, Sun D, Kaley G. (1993). Role of shear stress and endothelial prostaglandins in flow- and viscosity-induced dilation of arterioles in vitro. Circ Res 72:1276-1284.
76. Koller A, Sun D, Huang A, Kaley G. (1994). Corelease of nitric oxide and prostaglandins mediates flow-dependent dilation of rat gracilis muscle arterioles. Am J Physiol 267:H326-H332.
77. Krum H, Viskoper RJ, Lacourciere Y, Budde M, Charlon V. (1998). The effect of an endothelin-receptor antagonist, bosentan, on blood pressure in patients with essential hypertension. Bosentan Hypertension Investigators. N Engl J Med 338:784-790.
78. Kuo L, Davis MJ, Chilian WM. (1990). Endothelium-dependent, flow-induced dilation of isolated coronary arterioles. Am J Physiol 259:H1063-H1070.
79. Laasko J, Mervaala E, Himberg JJ, Teravained TL, Karppanen H, Vapaatalo H, Lapatto R. (1998). Increased kidney xanthine oxidoreductase activity in salt induced experimental hypertension. Hypertension 32:902-906.
80. Laursen JB, Rajagopalan S, Galis Z, Tarpey M, Freeman BA. Harrison DG. (1997). Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension. Circulation 95(3): 588-593.
81. Lauth M, Berger M, Cattaruzza M, Hecker M. (2000). Elevated perfusion pressure upregulates endothelin-1 and endothelin B receptor expression in the rabbit carotid artery. Hypertension 35:648-654.
82. 2+ desensitization in vascular smooth muscle by activating the myosin light chain phosphatase. J Biol Chem 272:5063-5068.
83. Lemne CE, Lundeberg T, Theodorsson E, de Faire U. (1994). Increased basal concentrations of plasma endothelin in borderline hypertension. J Hypertension 12:1069-1074.
84. Le Noble JLML, Tangelder GJ, Slaaf DW, van Essen H, Reneman RS, Struyker-Bedier HA. (1990). A functional morphometric study of the cremaster muscle microcirculation in young spontaneously hypertensive rats. J Hypertension 8:741-748.
85. Levy BI, Ambrosio G, Pries AR, Struijker-Boudier HAJ. (2001). Microcirculation in hypertension: a new target for treatment? Circulation 104:735-740.
86. Lipowsky HH. (1995). Shear stress in the circulation. In: Flow-Dependent Regulation of Vascular Function (JA Bevan, G Kaley, GM Rubani, Eds.). Oxford University Press, New York.
87. Madden JA, Christman NJ. (1999). Integrin signaling, free radicals, and tyrosine kinase mediate flow constriction in isolated cerebral arteries. Am J Physiol 277:H2264-H2271.
88. Malinski T, Kapturczak M, Dayharsh J, Bohr D. (1993). Nitric oxide synthase activity in genetic hypertension. Biochem Biophys Res Commun 194: 654-658.
89. Matrougui K, Jacques M, Lévy BI, Henrion D. (1997). Impaired nitric oxide- and prostaglandin-mediated responses to flow in resistance arteries of hypertensive rats. Hypertension 30:942-947.
90. 2 in responses of cerebral arterioles during chronic hypertension. Am J Physiol 262: H539-H543.
91. Mayrovitz HN, Roy J. (1983). Microvascular blood flow: evidence indicating a cubic dependence on arteriolar diameter. Am J Physiol 245:H1031-H1038.
92. McMahon EG, Palomo MA, Brown MA, Bertenshaw SR, Carter JS. (1993). Effect of phosphoramidon (endothelin converting enzyme inhibitor) and BQ-123 (endothelin receptor subtype A antagonist) on blood pressure in hypertensive rats. Am J Hypertension 6:667-673.
93. Moncada S, Higgs A. (1993). The L-arginine-nitric oxide pathway. N Engl J Med 329:2002-2012.
94. Moreau P. (1998). Endothelin in hypertension: a role for receptor antagonists? Cardiovasc Res 39: 534-542.
95. Mulvany MJ. (1990). Structure and function of small arteries in hypertension. J Hypertension Suppl 8:S225-S232.
96. Nabulsi AA, Folsom AR, White A, Patsch W, Heiss G, wu KK, Szklo M. (1993). Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. N Engl J Med 328:1069-1075.
97. Nakazono K, Watanabe N, Matsuno K, Sasaki J, Sato T, Inoue M. (1991). Does superoxide underlie the pathogenesis of hypertension? Proc Natl Acad Sci USA 88:10045-10048.
98. Newaz MA, Adeeb NN, Muslim N, Razak TA, Htut NN. (1996). Uric acid, xanthine oxidase and other risk factors of hypertension in normotensive subjects. Clin Exp Hypertension 18(8):1035-1050.
99. Nishikawa Y, Stepp DW, Chilian WM. (2000). Nitric oxide exerts feed back inhibition on EDHF-induced coronary arteriolar dilation in vivo. Am J Physiol 279(2):H459-H465.
100. Nishimura J, Breemen C. (1989) Direct regulation of smooth muscle contractile elements by second messengers. Biochem Biophys Res Commun 163:929-935.
101. Node K, Kitakaze M, Yoshikawa H, Kosaka H, Hori M. (1997). Reduced plasma concentrations of nitrogen oxide in individuals with essential hypertension. Hypertension 30(part 1):405-408.
102. Norrelund, H. Christensen KE, Samani NJ, Kimber P, Mulvany MJ, Korsgaard N. (1994). Early narrowed afferent arteriole is a contributor to the development of hypertension. Hypertension 24:301-308.
103. Obara K, Hata S, Sato K, Koide M, Ishii K, Nakayama K. (1999). Contractile potentiation by endothelin-1 involves protein kinase C-δ activity in the porcine coronary artery. Jpn J Physiol 49:175-183.
104. Osol G. (1995). Mechanotransduction by vascular smooth muscle. J Vasc Res 32:275-292.
105. Osol G, Laher I, Cipolla M. (1991). Protein kinase C modulates basal myogenic tone in resistance arteries from the cerebral circulation. Circ Res 68:359-367.
106. Osol G, Halpern W. (1985). Myogenic properties of cerebral blood vessels from normotensive and hypertensive rats. Am J Physiol 249:H914-H921.
107. Panza JA, Quyyumi AA, Callahan TS, Epstein SE. (1993). Effect of antihypertensive treatment on endothelium-dependent vascular relaxation in patients with essential hypertension. J Am Coll Cardiol 21(5):1145-1151.
108. Parkington HC, Tare M, Tonta MA, Coleman HA. (1993). Stretch revealed three components in the hyperpolarization of guinea-pig coronary artery in response to acetylcholine. J Physiol 465:459-476.
109. Prewitt RL, Wang DH, Hill MA. (1994). The pathophysiology of the microcirculation In: Hypertension (NA Mortillaro, AE Taylor, Eds.) CRC Press. Boca Raton, FL, 61-86.
110. Qiu, HY, Henrion, D, Benessiano, J, Heymes, C, Tournier, B, Levy, BI. (1998). Decreased flow-induced dilation and increased production of cGMP in spontaneously hypertensive rats. Hypertension 32:1098-1103.
111. Rajagopalan S, Kurz S, Munzel T, Tarpey M, Freemena BA, Grindling KK, Harrison DG. (1996). Angiotensin II-mediated hypertension in rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. J Clin Invest 97: 1916-1923.
112. Rizzoni D, Porteri E, Castellano M, Bettoni G, Muiesan ML, Tiberio C, Giulini SM, Rossi G, Bernini G, Agabiti-Rosei E. (1998). Endothelial dysfunction in hypertension is independent from the etiology and from vascular structure. Hypertension 31(part 2): 335-341.
113. Rosselli M, Imthurn B, Keller PJ, Jacson EK, Dubey RK. (1995). Circulating nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17-βestradiol and norethisterone acetate: a two-year follow-up study. Hypertension 25(part 2):848-853.
114. Roy JW, and Mayrovitz HN. (1984). Microvascular pressure, flow and resistance in spontaneously hypertensive rats. Hypertension 6:877-886.
115. + and barium. In: Resistance Arteries, Structure and Function (Mulvany MJ, Aalkjaer C, Heagerty AM, Nyborg NCB, Strandgaard S., Eds.) Elsevier Science. Amsterdam.
116. Ryan SM, Waack BJ, Weno BL, Heistad DD. (1995). Increase in pulse pressure impair acetylcholine-induced vascular relaxation. Am J Physiol 37:H359-H363.
117. 2+ sensitivity of contractile elements via protein kinase C in α-toxin permeabilized SMA from young spontaneously hypertensive rats. Cardiovasc Res 36:86-91.
118. Schiffrin EL, Deng LY, Sventek P, Day R. (1997). Enhanced expression of endothelin-1 gene in resistance arteries in severe human essential hypertension. J Hypertension 15:57-63.
119. Schiffrin EL, Thibault C. (1991). Plasma endothelin in human essential hypertension. Am J Hypertension 4:303-308.
120. Schmid-Schoenbein GW, Seiffge D, Delano FA, Shen K, Zweifach BW. (1991). Leukocyte counts and activation in spontaneously hypertensive and normotensive rats. Hypertension 17(3):323-330.
121. Skov K, Fenger-Gron J, Mulvany MJ. (1996). Effects of an angiotensin-converting enzyme inhibitor, a calcium antagonist, and an endothelin receptor antagonist on renal afferent arteriolar structure. Hypertension 28:464-471.
122. Smiesko V, Lang DJ, Johnson PC. (1989). Dilator response of rat mesenteric arcading arterioles to increased blood flow velocity. Am J Physiol 257(26): H1958-H1965.
123. Soloviev AI, Bershtein SA. (1992). The contractile apparatus in vascular smooth muscle cells of spontaneously hypertensive rats possess increased calcium sensitivity: the possible role of protein kinase C. J Hypertension 10:131-136.
124. Sudhir K, Jennings GL, Funder JW, Komesaroff PA. (1996). Estrogen enhances basal nitric oxide release in the forearm vasculature in perimenopausal women. Hypertension 28:330-334.
125. Sun D, Kaley G, Koller A. (1994). Characteristics and origin of myogenic response in isolated gracilis muscle arterioles. Am J Physiol 266:H1177-H1183.
126. Suzuki H, Zweifach BW, Schmid-Schoenbein GW. (1996). Glucocorticoid modulates vasodilator response of mesenteric arterioles in spontaneously hypertensive rats. Hypertension 27:114-118.
127. Suzuki H, DeLano FA, Parks DA, Jamshidi N, Granger DN, Ishii H, Suematus M, Zweifach BW, Schmid-Schoenbein GW. (1998). Xanthine oxidase activity associated with arterial blood pressure in spontaneously hypertensive rats. Proc Natl Acad Sci USA 95:4754-4759.
128. Suzuki H, Swei A, Zweifach BW, Schmid-Schöenbein GW. (1995). In vivo evidence for microvascular oxidative stress in spontaneously hypertensive rats: hydroethidine micro/fluorography. Hypertension 25:1083-1089.
129. Swei A, Lacy F, DeLano FA, Schmid-Schönbein GW. (1997). Oxidative stress in the Dahl hypertensive rat. Hypertension 30:1628-1633.
130. Taddei S, Virdis A, Ghiadoni L, Sudano I, Notari M, Salvetti A. (1999). Vasoconstriction to endogenous endothelin-1 is increased in the peripheral circulation of patients with essential hypertension. Circulation 100:1680-1683.
131. Tesfamariam B, Halpern W. (1988). Endothelium-dependent and endothelium-independent vasodilation in resistance arteries from hypertensive rats. Hypertension 11:440-444.
132. Tran, NN, Spitzbarth E, Robert A, Giummelly P, Atkinson J, Capdeville-Atkinson C. (1998). Nitric oxide lowers the calcium sensitivity of tension in the rat tail artery. J Physiol 507:163-174.
133. 2+ by sarcoplasmic reticulum in vascular smooth muscle. Circ Res 62:961-964.
134. 2+ channels and protein kinase C. Cardiovasc Res 43: 1018-1028.
135. 2+ sensitivity of arteriolar smooth muscle. Hypertension 36:856-861.
136. Ungvari Z, Koller A. (2001). Hypertension enhances gap junctions-mediated arteriolar myoendothelial coupling. Circulation 104.
137. 2+ sensitivity. J Appl Physiol 91:522-527.
138. + channels, 5,6-EET, and gap junctions. Microcirculation 8:265-274.
139. i in activation of eNOS in pressurized arterioles by agonists and wall shear stress. Am J Physiol Heart Circ Physiol 281:H606-H612.
140. 2+ sensitivity of arteriolar smooth muscle. Hypertension 36:856-861.
141. Ca channels and via gap junctions elicits EDHF-type arteriolar dilation. Am J Physiol Heart Circ Physiol 282:H1760-H1767.
142. VanBavel E, Wesselman JP, Spaan JA. (1998). Myogenic activation and calcium sensitivity of cannulated rat mesenteric small arteries. Circ Res 82:210-220.
143. Verdecchia P, Schillaci G, Reboldi GP, Santeusanio F, Porcellati C, Brunetti P. (2000). Relation between serum uric acid and risk of cardiovascular disease in essential hypertension. The PIUMA study. Hypertension 36:1072-1078.
144. Walsh BW, Schiff I, Rosner B, Greenber L, Ravnikar V, Sacks FM. (1991). Effects of postmenopausal estrogen replacement on the concentration and metabolism of plasma lipoproteins. N Engl J Med 325: 1196-1204.
145. Wang JG, Staessen JA, Fagard RH, Birkenhager WH, Gong L, Liu L. (2001). Prognostic significance of serum creatinine and uric acid in older Chinese patients with isolated systolic hypertension, Hypertension 37:1069-1074.
146. Weiner CP, Lizasoain I, Baylis SA, Knowles RG, Charles IG, Moncada S. (1994). Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc Natl Acad Sci USA 91:5212-5216.
147. + channels through a cGMP-dependent mechanism. Circ Res 77(5):936-942.
148. William SP, Shackford DP, lams SG, Mustafa SJ. (1988). Endothelium dependent relaxation in estrogen-treated spontaneously hypertensive rats. Eur J Pharmacol 145:205-207.
149. Xia Y, Tsai AL, Berka V, Zweier JL. (1998). Superoxide generation from endothelial nitric oxide synthase. J Biol Chem 273(40):25804-25808.
150. i in myogenic reactivity and arteriolar tone. Am J Physiol 269:H1590-H1596.
151. 2+ concentrations measured with fura-2. Br J Pharmacol 98: 469-482.